Sfoglia per Autore
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients
2012 D. Cattaneo, C. Gervasoni, V. Cozzi, S. Baldelli, S. Fucile, P. Meraviglia, S. Landonio, G. Boreggio, G. Rizzardini, E.G.I. Clementi
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients
2012 D. Cattaneo, D. Ripamonti, C. Gervasoni, S. Landonio, P. Meraviglia, S. Baldelli, V. Cozzi, S. Fucile, E. Clementi
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
2013 D. Cattaneo, G. Orlando, V. Cozzi, L. Cordier, S. Baldelli, S. Merli, S. Fucile, C. Gulisano, G. Rizzardini, E.G.I. Clementi
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers
2014 M.V. Cossu, D. Cattaneo, S. Fucile, P. Pellegrino, S. Baldelli, V. Cozzi, A. Capetti, E. Clementi
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint
2014 D. Cattaneo, S. Baldelli, S. Castoldi, N. Charbe, V. Cozzi, S. Fucile, E. Clementi
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study
2015 D. Cattaneo, M.V. Cossu, S. Fucile, A. Riva, S. Baldelli, P. Meraviglia, S. Landonio, C. Impagnatiello, C. Resnati, M. Galli, E. Clementi, A. Capetti, G. Rizzardini, C. Gervasoni
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples
2015 S. Baldelli, S. Castoldi, N. Charbe, V. Cozzi, S. Fucile, D. Cattaneo, E. Clementi
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma
2016 S. Baldelli, D. Cattaneo, P. Pignatelli, V. Perrone, D. Pastori, S. Radice, F. Violi, E. Clementi
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients : an observational study in real-life settings
2016 M. Pozzi, D. Cattaneo, S. Baldelli, S. Fucile, A. Capuano, C. Bravaccio, L. Sportiello, S. Bertella, F. Auricchio, R. Bernardini, C. Ferrajolo, G. Guastella, E. Mani, C. Carnovale, S. Pisano, C. Rafaniello, M.P. Riccio, R. Rizzo, M.G. Scuderi, S. Sperandeo, L. Villa, A. Pascotto, M. Molteni, F. Rossi, S. Radice, E. Clementi
Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?
2016 D. Cattaneo, M. Puoti, S. Sollima, C. Moioli, C.U. Foppa, S. Baldelli, E. Clementi, C. Gervasoni
Determinants of bone diseases in tenofovir-treated HIV patients
2016 C. Gervasoni, D. Minisci, P. Meraviglia, S. Baldelli, E. Clementi, G. Rizzardini, D. Cattaneo
When food can make the difference : The case of elvitegravir-based co-formulation
2016 D. Cattaneo, S. Baldelli, D. Minisci, P. Meraviglia, E. Clementi, M. Galli, C. Gervasoni
Identification of different patterns of dabigatran in vivo bioactivation in patients on maintenance anticoagulation therapy
2016 S. Baldelli, D. Cattaneo, M. Cerea, P. Pignatelli, F. Violi, E. Clementi
Therapeutic drug management of linezolid : a missed opportunity for clinicians?
2016 D. Cattaneo, C. Gervasoni, V. Cozzi, S. Castoldi, S. Baldelli, E. Clementi
Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study
2017 C. Rovera, M.C. Mauri, C. Di Pace, S. Paletta, A. Reggiori, V. Ciappolino, D. Cattaneo, S. Baldelli, E. Clementi, A.C. Altamura
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma
2017 S. Baldelli, G. Marrubini, D. Cattaneo, E. Clementi, M. Cerea
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics?
2017 S. Baldelli, E. Clementi, D. Cattaneo
Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations : A Case Series of Bipolar Type 2 Patients
2017 C. Rovera, C. Esposito, V. Ciappolino, D. Cattaneo, S. Baldelli, E.G.I. Clementi, A.C. Altamura, M. Buoli
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF
2018 D. Cattaneo, D. Minisci, S. Baldelli, C. Mazzali, A. Giacomelli, L. Milazzo, P. Meraviglia, C. Resnati, G. Rizzardini, E. Clementi, M. Galli, C. Gervasoni
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid
2018 S. Castoldi, V. Cozzi, S. Baldelli, S. Fucile, E. Clementi, D. Cattaneo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile